2017 American Transplant Congress
In Mid Wait Regions Shorter Height and Female Sex Confer Lower Probability of Liver Transplant (LT) Among Patients with Hepatocellular Carcinoma (HCC).
In the United States (U.S.) median MELD score at LT varies by region. Women without MELD exception have known longer wait times than men, which…2017 American Transplant Congress
Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis.
Background: Data on patient and graft outcomes of kidney transplant recipients with end stage renal disease (ESRD) from systemic amyloidosis is scarce. Methods: We performed…2017 American Transplant Congress
Predictors of Malignancies Across Solid Organ Transplantation.
Background & Aims:Solid organ transplant recipients are at much higher risk of cancer as compared to the general population. The aim of this study was…2017 American Transplant Congress
Donor Derived Transmission Events in 2015-2016: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
1DTAC, Richmond; 2United Network for Organ Sharing, Richmond
The OPTN DTAC, a multidisciplinary committee, evaluates potential donor derived transmission events (PDDTE), including mostly infections (I) & malignancies (M), to assess for likelihood of…2017 American Transplant Congress
10 Years of DTAC Experience with Kaposi's Sarcoma – Not Just Another PTLD!
1DTAC, Richmond; 2United Network for Organ Sharing, Richmond
Background:Kaposi's Sarcoma (KS), a tumor derived from the oncogenic virus human herpesvirus-8 (HHV8) is strongly associated with immunodeficiencies. Classically seen with AIDS, it can also…2017 American Transplant Congress
Risk of Primary Central Nervous System Lymphoma in Solid Organ Transplant Recipients.
National Cancer Institute, Bethesda, MD
Background: Risk of primary central nervous system lymphoma (PCNSL) is greatly increased in immunosuppressed HIV-infected people. Case series describe PCNSL in solid organ transplant (SOT)…2017 American Transplant Congress
The Effiency and Safety of Chemotherapy for Urothelial Carcinoma in Post-Kidney Transplanted Patients.
Urology, Capital Medical University Beijing Friendship Hospital, Beijing, China
Objective: According to our published data, upper tract urothelial carcinoma (UTUC) is the predominant malignancy among Chinese renal transplanted patients. This is quite different from…2017 American Transplant Congress
HCC and Cardiac Cirrhosis After the Fontan Procedure in a Patient with Congenital Heart Disease and Situs Inversus.
Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX
Introduction. Hypoplastic left heart syndrome (HLHS) is a fatal congenital cardiac anomaly for which surgical palliation is needed, the Fontan procedure. HLHS accounts for <5%…2017 American Transplant Congress
Long-Term Malignancy Risk in Kidney Transplant Recipients Treated with Cyclophosphamide Pre-Transplant for Native Glomerular Disease.
1Pharmacy, UW Health, Madison, WI; 2Nephrology, UW Health, Madison, WI
Purpose: To evaluate the incidence of malignancy in kidney transplant recipients who previously received cyclophosphamide for treatment of native glomerular disease.Methods: Single center study of…2017 American Transplant Congress
Solid Organ Cancer After Kidney Transplantation: Risk Factors and Long Term Impact.
Nephrology Department, Hospital del Mar, Barcelona, Spain
Cancer after kidney transplant (KT) is the only cause of death that is increasing. We analyzed incidence, risk factors and characteristics of postKT solid cancers…
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 20
- Next Page »